Martin Yarmush is the founding editor of the Annual Review of Biomedical Engineering which was first published in 1999 by the nonprofit publisher Annual Reviews.
13 Facts About Martin Yarmush
1.
2.
Martin Yarmush is a series editor for the book series Frontiers In Nanobiomedical Research.
3.
Martin Yarmush attended the Hebrew Institute of Boro Park, Yeshiva University High School of Brooklyn, Yeshiva University, The Rockefeller University, Yale University School of Medicine, and the Massachusetts Institute of Technology.
4.
Martin Yarmush has worked as a professor at MIT, Harvard, and Rutgers and has held adjunct positions at the University of Pennsylvania School of Veterinary Medicine.
5.
Martin Yarmush is known for his scholarly contributions to many areas of biotechnology and bioengineering; and for the many students and fellows that he has trained who have gone on to significant academic and industrial careers.
6.
Martin Yarmush serves as the founding director of the National Institutes of Health - Rutgers Predoctoral Biotechnology Training Program which has received continuous financial support from the NIH for 35 years.
7.
At the time, Martin Yarmush was the Helen Andrus Benedict Professor of Surgery and Bioengineering in the Harvard-MIT Division of Health Sciences and Technology and at Harvard Medical School.
8.
Martin Yarmush currently holds the Paul and Mary Endowed Chair in Science and Engineering at Rutgers University and serves as a Distinguished Professor in the Department of Biomedical Engineering.
9.
Martin Yarmush holds a Bioengineer position at the Massachusetts General Hospital, a Lecturer in Surgery and Bioengineering position at Harvard Medical School, and a Senior Scientific Staff position at the Shriners Children's, Boston.
10.
Martin Yarmush has filed patent applications for more than 60 inventions in medical and technical fields and is a member of the National Academy of Inventors, and the National Academy of Engineering.
11.
Martin Yarmush has worked on wound healing, metabolic engineering, dynamic microfabricated cell and tissue systems, biomedical devices, cell therapies, tissue engineering and regenerative medicine, including the development of non-invasive treatments to prevent scarring after burns.
12.
Martin Yarmush has led a team that has developed storage protocols that can increase the amount of time that a donor organ can be stored and still be viable for use in human transplant operations.
13.
Martin Yarmush has pioneered the field of automated image-guided robotic vascular access and led the development of a robot for drawing blood samples which can be analyzed with a point-of-care downstream processing and analysis system.